Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-08-15

Clinical Trial Update: Effect of Sevoflurane, Propofol and Dexmedetomidine on Delirium & Neuroinflammation in Mechanically Ventilated Patients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating effects of sevoflurane, propofol, and dexmedetomidine on delirium and neuroinflammation in mechanically ventilated patients; study w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • PROPOFOL (Propofol)
  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: Moscow Regional Research and Clinical Institute (MONIKI) | Conditions: Delirium | Phase 4 | Status: WITHDRAWN